JB MULTI BONUS CERTIFICATE - ALIBABA GROUP ADR/BAYER | Market Closed - Swiss Exchange 16:20:00 03/06/2024 BST | ||
| 596 USD | +1.53% |
|
| Current month | +1.53% | ||
| 3 months | -0.33% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BAYER AG
| Date | Price | Change |
|---|---|---|
| 03/06/24 | 596 | +1.53% |
| 31/05/24 | 587 | +0.69% |
| 30/05/24 | 583 | +2.19% |
| 29/05/24 | 570.5 | -3.22% |
Delayed Quote Swiss Exchange
Last update June 03, 2024 at 04:20 pm
More quotesStatic data
| Product type | Bonus- and Part-Guarantee-Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | BAYER AG |
| Issuer | Bank Julius Bär |
| MBJQJB | |
| ISIN | CH1255578085 |
| Date issued | 29/06/2023 |
| Strike | 78.08 € |
| Maturity | 30/06/2025 (391 Days) |
| Parity | 0.08 : 1 |
| Emission price | 1,000 $ |
| Emission volume | N/A |
| Settlement | cash |
| Currency | USD |
Technical Indicators
| Highest since issue | 1,085 $ |
|---|---|
| Lowest since issue | 536 $ |
| Spread | 16.5 $ |
| Spread % | 2.73% |
Company Profile
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
-
Consensus: Bayer AG
Sell
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
28.34
EUR
Average target price
36.64
EUR
Spread / Average Target
+29.30%
- Stock Market
- Certificates
- MBJQJB Certificat